|
The graft versus host disease drugs to use |
May contain organization-specific values: Yes |
Category Entries: |
Tacrolimus (FK 506) |
Cyclosporine (CSA, Neoral, Sandimmune) |
Mycophenolate mofetil (MMF) (CellCept) |
Sirolimus (Rapamycin, Rapamune) |
Methotrexate (MTX) (Amethopterin) |
ALG/ALS/ATG/ATS |
Extra-corporeal photopheresis (ECP) |
Etanercept |
Alemtuzumab |
In vivo immunotoxin |
Infliximab |
Cyclophosphamide (Cytoxan) |
Anti CD 25 (Zenapax, Daclizumab, AntiTAC) |
Other agent |
In vivo monoclonal antibody |
Blinded randomized trial |
Corticosteroids (systemic) |
Everolimus |
Abatacept |
Bortezomib |
CD34 enriched (CD34+ selection) |
Ex-vivo T-cell depletion |
Filgotinib |
Maraviroc |
Ruxolitinib |
Tocilizumab |